220 related articles for article (PubMed ID: 21520044)
1. A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells.
Lin L; Benson DM; DeAngelis S; Bakan CE; Li PK; Li C; Lin J
Int J Cancer; 2012 Mar; 130(6):1459-69. PubMed ID: 21520044
[TBL] [Abstract][Full Text] [Related]
2. A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.
Lin L; Hutzen B; Li PK; Ball S; Zuo M; DeAngelis S; Foust E; Sobo M; Friedman L; Bhasin D; Cen L; Li C; Lin J
Neoplasia; 2010 Jan; 12(1):39-50. PubMed ID: 20072652
[TBL] [Abstract][Full Text] [Related]
3. The small molecule, LLL12, inhibits STAT3 phosphorylation and induces apoptosis in medulloblastoma and glioblastoma cells.
Ball S; Li C; Li PK; Lin J
PLoS One; 2011 Apr; 6(4):e18820. PubMed ID: 21526200
[TBL] [Abstract][Full Text] [Related]
4. Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice.
Onimoe GI; Liu A; Lin L; Wei CC; Schwartz EB; Bhasin D; Li C; Fuchs JR; Li PK; Houghton P; Termuhlen A; Gross T; Lin J
Invest New Drugs; 2012 Jun; 30(3):916-26. PubMed ID: 21340507
[TBL] [Abstract][Full Text] [Related]
5. Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells.
Wei CC; Ball S; Lin L; Liu A; Fuchs JR; Li PK; Li C; Lin J
Int J Oncol; 2011 Jan; 38(1):279-85. PubMed ID: 21109950
[TBL] [Abstract][Full Text] [Related]
6. LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy.
Zuo M; Li C; Lin J; Javle M
Oncotarget; 2015 May; 6(13):10940-9. PubMed ID: 25883212
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic activity of a small molecule STAT3 inhibitor LLL12.
Bid HK; Oswald D; Li C; London CA; Lin J; Houghton PJ
PLoS One; 2012; 7(4):e35513. PubMed ID: 22530037
[TBL] [Abstract][Full Text] [Related]
8. LLL12 inhibits endogenous and exogenous interleukin-6-induced STAT3 phosphorylation in human pancreatic cancer cells.
Liu A; Liu Y; Li PK; Li C; Lin J
Anticancer Res; 2011 Jun; 31(6):2029-35. PubMed ID: 21737619
[TBL] [Abstract][Full Text] [Related]
9. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells.
Bharti AC; Donato N; Aggarwal BB
J Immunol; 2003 Oct; 171(7):3863-71. PubMed ID: 14500688
[TBL] [Abstract][Full Text] [Related]
10. A small molecule STAT3 inhibitor, LLL12, enhances cisplatin‑ and paclitaxel‑mediated inhibition of cell growth and migration in human ovarian cancer cells.
Zhang R; Chen X; Fu S; Xu L; Lin J
Oncol Rep; 2020 Sep; 44(3):1224-1232. PubMed ID: 32705214
[TBL] [Abstract][Full Text] [Related]
11. Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines.
Couto JI; Bear MD; Lin J; Pennel M; Kulp SK; Kisseberth WC; London CA
BMC Vet Res; 2012 Dec; 8():244. PubMed ID: 23244668
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells.
Liu Y; Li PK; Li C; Lin J
J Biol Chem; 2010 Aug; 285(35):27429-27439. PubMed ID: 20562100
[TBL] [Abstract][Full Text] [Related]
13. A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells.
Xiao H; Bid HK; Jou D; Wu X; Yu W; Li C; Houghton PJ; Lin J
J Biol Chem; 2015 Feb; 290(6):3418-29. PubMed ID: 25313399
[TBL] [Abstract][Full Text] [Related]
14. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L
Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells.
Lin L; Hutzen B; Lee HF; Peng Z; Wang W; Zhao C; Lin HJ; Sun D; Li PK; Li C; Korkaya H; Wicha MS; Lin J
PLoS One; 2013; 8(12):e82821. PubMed ID: 24376586
[TBL] [Abstract][Full Text] [Related]
16. Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway.
Li F; Rajendran P; Sethi G
Br J Pharmacol; 2010 Oct; 161(3):541-54. PubMed ID: 20880395
[TBL] [Abstract][Full Text] [Related]
17. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
[TBL] [Abstract][Full Text] [Related]
18. STAT3 is necessary for proliferation and survival in colon cancer-initiating cells.
Lin L; Liu A; Peng Z; Lin HJ; Li PK; Li C; Lin J
Cancer Res; 2011 Dec; 71(23):7226-37. PubMed ID: 21900397
[TBL] [Abstract][Full Text] [Related]
19. LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells.
Chen X; Pan L; Wei J; Zhang R; Yang X; Song J; Bai RY; Fu S; Pierson CR; Finlay JL; Li C; Lin J
Sci Rep; 2021 Mar; 11(1):6517. PubMed ID: 33753770
[TBL] [Abstract][Full Text] [Related]
20. Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation.
Bhutani M; Pathak AK; Nair AS; Kunnumakkara AB; Guha S; Sethi G; Aggarwal BB
Clin Cancer Res; 2007 May; 13(10):3024-32. PubMed ID: 17505005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
